1 min read

Your Data Is Stronger in Context: Meta-Analysis Grows Up

By Tim Wesselman on Jul 15, 2025, 9:00:00 AM

A single experiment is a data point. Its meaning almost always emerges in context: next to other studies, other conditions, other modalities. That's the whole premise of meta-analysis, and it's an area we've invested heavily in this release.

Combine your data with curated references

You can now include Library experiments directly in a meta-analysis, combining your own data with curated reference datasets in one analysis. That's a meaningful shift: your experiment stops being an island and starts being part of a larger conversation, measured against a growing body of reference data rather than in isolation.

Sharper, faster, more flexible

  • Building a meta-analysis is faster, with streamlined experiment selection and cluster configuration.
  • You can select gene lists from Gene List Manager when configuring a cluster, so your curated gene sets drive the comparison.
  • You can run meta-analyses on single clusters with modified annotations, for focused, targeted contrasts.
  • The results page reads more clearly, with improved hypersummary display and heatmap rendering.

Now spanning modalities

Perhaps the most exciting part: GeoMx DSP spatial experiments can now join meta-analyses alongside your bulk and single-cell data. Multiomic, cross-modality integration is one of the defining trends in the field right now: the recognition that no single assay tells the whole story. Bringing spatial into the same analytical frame as everything else is a real step toward that.

And to make all this practical at scale, large exports now stream directly from storage, so multi-gigabyte downloads finish reliably instead of timing out. The more your data connects to other data, the more valuable each experiment becomes. That's not a small idea. It's a mindset shift we've been building toward for a while: from analyzing experiments one at a time to treating a growing, curated body of data as a single, queryable resource. Meta-analysis is where that shift becomes tangible, and building the place where all those connections live is exactly where we want Rosalind to be.

Tim Wesselman

Written by Tim Wesselman

Tim Wesselman is Founder of Rosalind (formerly OnRamp Bio) and CEO since 2013. For the 20 years prior to starting Rosalind, Tim had been dedicated to understanding next-generation servers and storage solutions. Serving as Vice President at Hewlett-Packard, he led strategy & partnerships with the market leaders in big data software, advanced processors and cloud computing. These partners included known names, like FaceBook, MapR, Cloudera and DataStax with solutions that companies like Apple, Amazon, Microsoft, Baidu and many others heavily rely on today. Seeing the opportunity to bring this knowledge of advanced computing technology into the healthcare space, Tim founded and launched Rosalind to empower researchers, doctors and drug developers to accelerate genomic discoveries through collaboration so that we all can realize the promise of precision medicine and unlock biology's greatest unknowns.